Takeda
Bookmark
ShareTakeda is a company. It is in Tokyo, Japan and it has a male CEO called Christophe Weber. It was founded in 1986 and is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Tokyo
- country: Japan
- employees: 47,347 people
- revenues: 24.9B $
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1986
- CEO: Christophe Weber
- CEO gender: male
- CEO approval: 89 %
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Takeda:
Stocks from Takeda:
Takeda is one of the companies in Christophe Weber, companies in Japan, companies in Pharmaceuticals, companies in Health Care and 3,584,319 companies in our database.
Talking Points
- Takeda Pharmaceuticals: Global Homepage
- Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
- Official Twitter handle of Takeda Pharmaceutical | Better Health, Brighter Future. Read more: https://t.co/nmqpeoLZRV
- Takeda has been putting patients first for more than two centuries. We are a global, science-driven biopharmaceutical leader with headquarters in Japan and the U.S., guided by our Patient-Trust-Reputation-Business philosophy. This perspective represents who we are and guides how we act, helping us make decisions we can be proud of today and in the future.
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc.; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
